Xylo Technologies (Xylo Technologies) Inventories, Finished Goods

: $0.0 Mil (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

Xylo Technologies's quarterly finished goods declined from Jun. 2022 ($1.8 Mil) to Dec. 2022 ($1.8 Mil) and declined from Dec. 2022 ($1.8 Mil) to Jun. 2023 ($0.0 Mil).

Xylo Technologies's annual finished goods increased from Dec. 2020 ($0.3 Mil) to Dec. 2021 ($1.2 Mil) and increased from Dec. 2021 ($1.2 Mil) to Dec. 2022 ($1.8 Mil).

Xylo Technologies Inventories, Finished Goods Historical Data

The historical data trend for Xylo Technologies's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xylo Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Inventories, Finished Goods

0.02

0.58

0.28

1.23

1.79

Xylo Technologies Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Inventories, Finished Goods																1.09	1.23	1.83	1.79	-

Xylo Technologies Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Xylo Technologies (Xylo Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xylo Technologies Ltd (NAS:XYLO) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

2QM0:Germany

Address

10 Hanechoshet Street, 4th Floor, Tel Aviv, ISR, 6971072

Website

https://www.medigus.com

Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.